XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Segment Reporting      
Number of operating segments | segment 1    
Less:      
General and administrative $ 2,989 $ 3,549  
Equity-based compensation 586 1,171  
Net loss (8,480) (9,151) $ (33,971)
Life science segment      
Segment Reporting      
Grant Income 5,086 4,912  
Less:      
Clinical programs 6,877 6,398  
R&D Personnel costs 2,792 2,626  
Preclinical programs 85 235  
Manufacturing 637 1,004  
Other research and development expenses 85 59  
General and administrative 2,713 2,609  
Equity-based compensation 586 1,171  
Other segment items (209) (39)  
Net loss $ (8,480) $ (9,151)  
Other segment reporting description Other segment items include, Other income, net, Interest expense and Loss on currency translation from liquidation of subsidiary. Other segment items include, Other income, net, Interest expense and Loss on currency translation from liquidation of subsidiary.